KFF March 5, 2024

The first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores.

Although the new over-the-counter pill could broaden access to contraceptive options in the United States, KFF research suggests consumers are likely to face some hurdles if they seek to have their plan cover the costs. For example, while federal policy requires most private health insurance plans and Medicaid expansion programs to cover—without patient copays—the full range of FDA-approved contraceptive methods with a prescription, there is no federal requirement that plans cover nonprescription contraception.

As Opill officially launches and federal regulators consider public input on how best to ensure coverage and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
Healthcare supply chain, pharmacy costs to rise in 2025: report
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
Behind Intermountain Health's in-house PBM

Share This Article